H.C. Wainwright lowered the firm’s price target on Sarepta (SRPT) to $75 from $80 and keeps a Sell rating on the shares. Sarepta’s deal to ...
Sarepta Therapeutics (SRPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kostas ...
11月26日宣布的Sarepta与Arrowhead Pharmaceuticals (NASDAQ:ARWR)的最新合作关系重新引发了投资者的浓厚兴趣。消息公布后,Sarepta股价在收盘时上涨了14%。这笔交易被视为一个积极举措,解决了人们对近期催化剂和长期可持续增长的担忧。
Hailing from Belgharia in Kolkata, 22-year-old Sayan Ghosh had traveled to Bangladesh on November 23. He stayed with a friend’s family.